Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Shanghai 133 Nanjing 4 Tianjin 3 Zhengzhou 2 Shenzhen 2
Narrow the registerReset
Recruitment status
Phase
Site location
Shanghai133 Nanjing4 Tianjin3 Zhengzhou2 Shenzhen2
All 30 locations
Target enrolment
to

Trials with a site in Shanghai

133 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
GBP-213 in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT07891364Autosomal Dominant Polycystic Kidney
RenJi Hospital
Early Phase 1
24
Shanghai
2026-11
Not yet open
RenJi Hospital
Observational
40
Shanghai
2026-10-15
Not yet open
RenJi Hospital
Not applicable
68
Shanghai
2026-09-01
Recruiting
Plasma DNA Methylation for Preoperative Classification of Renal Masses
NCT07874542Renal Cell Carcinoma, Benign Renal Mass
RenJi Hospital
Observational
240
Shanghai
2026-09-01
Not yet open
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
NCT07811895Tirzepatide, Frozen Embryo Transfer, Obesity
RenJi Hospital
Not applicable
1,510
Shanghai
2026-09
Not yet open
FICB for Hip Fracture Pain in Elderly
NCT07762846Hip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures), Postoperative Pain, QoR-15, Fascia Iliaca Block
RenJi Hospital
Not applicable
144
Shanghai
2026-08
Not yet open
RenJi Hospital
Phase 4
124
Shanghai
2026-07-01
Recruiting
RenJi Hospital
Not applicable
140
Shanghai
2026-06-24
Not yet open
The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching
NCT07678645Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Atopic Dermatitis (AD)
RenJi Hospital
Phase 2
44
Shanghai
2026-06-01
Not yet open
HERO-UTUC: Intravesical RC48 After RNU for HER2+ UTUC
NCT07591805Upper Urinary Tract Urothelial Carcinoma
RenJi Hospital
Phase 2
49
Shanghai
2026-05-16
Recruiting
RenJi Hospital
Phase 2
55
Shanghai
2026-05-01
Recruiting
miRNA Panel for PCa Diagnosis
NCT07755592Prostate Cancer (Diagnosis)
RenJi Hospital
Observational
500
Shanghai
2026-04-13
Recruiting
RenJi Hospital
Phase 2
46
Shanghai
2026-03-01
Recruiting
Biochemical Response and Clinical Outcomes in Patients With PBC
NCT07449793Primary Biliary Cholangitis (PBC), Primary Biliary Cholangitis
RenJi Hospital
Observational
3,000
Shanghai
2026-02-01
Recruiting
RenJi Hospital
Not applicable
25
Shanghai
2025-12-19
Recruiting
RenJi Hospital
Not applicable
10
Shanghai
2025-11-28
Recruiting
Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
NCT07157631Liver Transplantation, Tranexamic Acid, End-stage Liver Disease (ESLD)
RenJi Hospital
Not applicable
1,546
Shanghai
2025-11-01
Recruiting
RenJi Hospital
Observational
150
Shanghai
2025-10-20
Not yet open
HAIC + Atezolizumab Plus Bevacizumab in Unresectable HCC
NCT07045558Unresectable Hepatocellular Carcinoma
RenJi Hospital
Observational
28
Shanghai
2025-08-01
Not yet open
EEG-TMS Intervening Against Postoperative Delirium
NCT07100197Postoperative Delirium
RenJi Hospital
Not applicable
98
Shanghai
2025-07-27
Not yet open
RenJi Hospital
Observational
40
Shanghai
2025-07-01
Active, closed
OCT in Endovascular Recanalization of Chronic Carotid Artery Occlusion
NCT07740408Chronic Internal Carotid Artery Occlusion, Carotid Artery Occlusion
RenJi Hospital
Observational
60
Shanghai
2025-07-01
Not yet open
REST4-AAA Registry
NCT07056491Abdominal Aortic Aneurysm
RenJi Hospital
Observational
70
Shanghai
2025-07-01
Active, closed
Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
NCT07193615Alpha-1 Antitrypsin Deficiency (AATD)
RenJi Hospital
Early Phase 1
18
Shanghai
2025-06-18
Not yet open
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
NCT06978946Alzheimer Disease, Lewy Body Dementia (LBD), Frontotemporal Dementia (FTD), Dementia
RenJi Hospital
Not applicable
85
Shanghai
2025-05-28
Recruiting
FGF19 Overexpression Combination Unified Study in HCC-19
NCT06978933HCC - Hepatocellular Carcinoma
RenJi Hospital
Phase 2
42
Shanghai
2025-04-30
Not yet open
RenJi Hospital
Phase 2
30
Shanghai
2025-04-05
Recruiting
RenJi Hospital
Not applicable
127
Shanghai
2025-04-01
Recruiting
RenJi Hospital
Observational
114
Beijing, Guangdong, Guizhou, Jiangsu, Shanghai, Sichuan, Tianjin, Zhejiang
2025-03-13
By invitation
A Study on Multimodal Prognostic Scoring of Advanced PDAC.
NCT07373691Pancreatic Ductal Adenocarcinoma (PDAC)
RenJi Hospital
Observational
100
Shanghai
2025-03-02
Recruiting
RenJi Hospital
Not applicable
20
Shanghai
2025-02-08
Not yet open
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
NCT06794710Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Metabolic Cardiomyopathy, Restrictive Cardiomyopathy
RenJi Hospital
Not applicable
300
Shanghai
2025-02-01
Not yet open
RenJi Hospital
Not applicable
1,976
Shanghai
2025-01-15
Recruiting
Prophylactic Tranexamic Acid Reduces Postpartum Hemorrhage
NCT06754371Postpartum Hemorrhage, Systemic Autoimmune Diseases
RenJi Hospital
Phase 4
276
Shanghai
2025-01-06
Not yet open
RenJi Hospital
Not applicable
10
Shanghai
2025-01
Recruiting
RenJi Hospital
Not applicable
100
Shanghai
2024-12-23
Recruiting
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638Renal Cancer, Renal Clear Cell Carcinoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse
RenJi Hospital
Phase 2
300
Shanghai
2024-12-23
Recruiting
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663Solid Tumor, Solid Carcinoma, Uroepithelial Carcinoma, Bladder Cancer
RenJi Hospital
Phase 2/3
400
Shanghai
2024-12-23
Not yet open
RenJi Hospital
Not applicable
92
Shanghai
2024-12-20
Recruiting
Target-specific immunoPET Imaging of Digestive System Carcinoma
NCT06715839Malignancy, Digestive Cancer, Digestive System Neoplasm, Digestive System Carcinoma
RenJi Hospital
Not applicable
400
Shanghai
2024-12-04
Recruiting
RenJi Hospital
Not applicable
236
Shanghai
2024-12-01
Recruiting
CD70-targeted immunoPET Imaging of Kidney Cancer
NCT06680089Urologic Neoplasms, Urogenital Neoplasms, Kidney Neoplasms, Neoplasms
RenJi Hospital
Phase 2
300
Shanghai
2024-11-27
Recruiting
A Survey on Growth Development in Children After Liver Transplantation
NCT07574398Growth, Development in Pediatric Liver Transplant Recipients
RenJi Hospital
Observational
275
Shanghai
2024-11-20
Recruiting
ImmunoPET Imaging of Pancreatic Cancer
NCT06602037Neoplasms Pancreatic
RenJi Hospital
Not applicable
90
Shanghai
2024-11-20
Recruiting
RenJi Hospital
Observational
358
Shanghai
2024-11-07
Recruiting
Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
NCT06994221Acute Myocardial Infarction, Ventricular Aneurysm Following Acute Myocardial Infarction, Myocardial Fibrosis
RenJi Hospital
Observational
20
Shanghai
2024-11-01
Active, closed
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
NCT06762158Esophageal Squamous Cell Carcinoma (ESCC)
RenJi Hospital
Not applicable
50
Shanghai
2024-10-30
Not yet open
RenJi Hospital
Phase 2
104
Shanghai
2024-10-30
Recruiting
RenJi Hospital
Phase 4
40
Shanghai
2024-10-16
Not yet open
RenJi Hospital
Not applicable
18
Shanghai
2024-10-09
Recruiting
Target-specific immunoPET Imaging of Breast Cancer
NCT06715826Breast Cancer, Breast Neoplasms, Breast Cancer Metastatic
RenJi Hospital
Phase 1/2
200
Shanghai
2024-09-21
Recruiting
RenJi Hospital
Not applicable
104
Shanghai
2024-09-01
Not yet open
JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases
NCT06567080B-cell Tumors, Autoimmune Diseases, Lupus Erythematosus, Systemic, Large B-cell Lymphoma
RenJi Hospital
Phase 1
15
Shanghai
2024-09
Not yet open
OXiris for Abdominal SEptic Shock (OASES Study)
NCT06504316Septic Shock, Abdominal Sepsis, Multi Organ Failure, Blood Purification
RenJi Hospital
Not applicable
192
Shanghai
2024-08-15
Recruiting
RenJi Hospital
Observational
50
Shanghai
2024-08-15
Not yet open
RenJi Hospital
Phase 2
80
Shanghai
2024-08-10
Active, closed
RenJi Hospital
Not applicable
12
Shanghai
2024-08-06
Recruiting
RenJi Hospital
Not applicable
1,115
Shanghai
2024-08-01
Recruiting
RenJi Hospital
Early Phase 1
21
Shanghai
2024-07-15
Recruiting
DRug-coAted Balloon Compared With cuttinG balloON in Treatment of Arteriovenous Fistula Stenosis
NCT06527963Arteriovenous Fistula, Angioplasty, Balloon, Hemodialysis Access Failure
RenJi Hospital
Observational
180
Zhengzhou, Nanjing, Shanghai
2024-07-01
Recruiting
RenJi Hospital
Not applicable
176
Shanghai
2024-06-28
Recruiting
A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients
NCT06469710Prostate Cancer, Circulating Tumor Cell, Leukapheresis
RenJi Hospital
Observational
50
Shanghai
2024-06-25
Recruiting
RenJi Hospital
Observational
180
Zhengzhou, Nanjing, Shanghai
2024-06-01
Not yet open
Study on the Efficacy of Long-term Drainage of Subdural Effusion After Decompressive Craniectomy
NCT06391203Traumatic Brain Injury, Decompressive Craniectomy, Subdural Effusion
RenJi Hospital
Not applicable
160
Shanghai
2024-06-01
Recruiting
RenJi Hospital
Early Phase 1
20
Shanghai
2024-05-24
Recruiting
Clinical Study of HIFU for Localized Prostate Cancer
NCT06362577Localized Prostate Cancer
RenJi Hospital
Observational
60
Shanghai
2024-05-21
Recruiting
RenJi Hospital
Not applicable
12
Shanghai
2024-05-07
Recruiting
Dalpiciclib in HR+/HER2- ABC
NCT06301438Advanced Breast Cancer
RenJi Hospital
Observational
103
Shanghai
2024-05-03
Recruiting
RenJi Hospital
Not applicable
201
Shanghai
2024-04-30
Recruiting
Wearable Devices Faciliate the Management of AMI Patients
NCT06995495Acute Myocardial Infarction
RenJi Hospital
Observational
400
Shanghai
2024-04-01
Recruiting
RenJi Hospital
Not applicable
192
Shanghai
2024-03-21
Recruiting
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
NCT06249438Systemic Lupus Erythematosus (SLE), Immune-mediated Necrotizing Myopathy (IMNM), Neuromyelitis Optica Spectrum Disorders (NMOSD), Multiple Sclerosis (MS)
RenJi Hospital
Phase 1
30
Shanghai
2024-03-20
Recruiting
RenJi Hospital
Not applicable
80
Shanghai
2024-03-04
Recruiting
RenJi Hospital
Not applicable
80
Shanghai
2024-03-01
Active, closed
Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma
NCT06279403Immune Checkpoint Inhibitors, Cytoreductive Nephrectomy, Clear Cell Renal Cell Cancer (ccRCC)
RenJi Hospital
Phase 2
21
Shanghai
2024-03-01
Recruiting
Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
NCT05727722Acute-On-Chronic Liver Failure, Chronic Liver Failure
RenJi Hospital
Phase 1
10
Shanghai
2024-03-01
Recruiting
RenJi Hospital
Observational
120
Shanghai
2024-03-01
By invitation
Intervention and Effect of Sleep Pattern on Cardio-cerebrovascular Disease
NCT06294964Cardiovascular Diseases, Non-Communicable Chronic Diseases
RenJi Hospital
Not applicable
12,800
Shanghai
2024-03-01
Recruiting
RenJi Hospital
Observational
180
Shanghai
2024-01-01
Active, closed
RenJi Hospital
Observational
462
Shanghai
2024-01-01
Recruiting
RenJi Hospital
Not applicable
1,200
Nanjing, Nanchang, Jinan, Shanghai, Xi’an, Tianjin, Hangzhou
2023-12-27
Recruiting
RenJi Hospital
Not applicable
120
Shanghai
2023-12-24
Not yet open
RenJi Hospital
Not applicable
60
Shanghai
2023-12-01
Not yet open
RenJi Hospital
Observational
40
Shanghai
2023-12-01
Recruiting
Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
NCT06204406Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
RenJi Hospital
Observational
106
Shanghai
2023-11-23
Recruiting
RenJi Hospital
Phase 2
22
Nanjing, Xi'an, Shanghai, Chengdu, Tianjin
2023-11-16
Recruiting
Cohort in Qianwan New District, Ningbo
NCT06387875Cardiovascular Diseases, Stroke, Non-Communicable Chronic Diseases
RenJi Hospital
Observational
30,000
Shanghai
2023-11-01
Recruiting
RenJi Hospital
Observational
480
Shanghai
2023-10-01
Recruiting
RenJi Hospital
Observational
240
Shanghai
2023-09-01
Recruiting
Obesity Queue Database
NCT06391320Obesity
RenJi Hospital
Observational
5,000
Shanghai
2023-09-01
Recruiting
RenJi Hospital
Observational
500
Shanghai
2023-09-01
Active, closed
RenJi Hospital
Phase 2
28
Shanghai
2023-08-23
Recruiting
Maximal Tumor Eradication for Oligometastatic Prostate Cancer
NCT06972511Oligometastatic Prostate Cancer
RenJi Hospital
Phase 2/3
120
Shanghai
2023-08-20
Not yet open
RenJi Hospital
Not applicable
100
Shanghai
2023-07-01
Recruiting
Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
NCT05912816Upper Urinary Tract Urothelial Carcinoma, Kidney Preservation, HER-2 ADC, PD-1antibody
RenJi Hospital
Phase 2
20
Shanghai
2023-06-10
Recruiting
RenJi Hospital
Observational
45
Shanghai
2023-06-01
Recruiting
RenJi Hospital
Phase 3
488
Shanghai
2023-06-01
Recruiting
RenJi Hospital
Not applicable
120
Shanghai
2023-05-31
Recruiting
RenJi Hospital
Early Phase 1
18
Shanghai
2023-05-11
Recruiting
RC48-ADC in HER2-low Advanced Breast Cancer
NCT05831878Advanced Breast Cancer
RenJi Hospital
Not applicable
36
Shanghai
2023-05-04
Active, closed
RenJi Hospital
Phase 2
40
Shanghai
2023-05-01
Recruiting
RenJi Hospital
Observational
172
Shanghai
2023-04-30
Recruiting
RenJi Hospital
Observational
480
Shanghai
2023-01-01
Recruiting
RenJi Hospital
Not applicable
12
Shanghai
2023-01-01
Recruiting
Pre-operative Therapy in Breast Cancer
NCT05621564Breast Cancer
RenJi Hospital
Observational
6,032
Shanghai
2022-11-01
Recruiting
RenJi Hospital
Not applicable
484
Shanghai
2022-09-14
Recruiting
RenJi Hospital
Not applicable
160
Shanghai
2022-09-01
Recruiting
Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment
NCT05326399Liver Transplantation, Renal Insufficiency, Chronic
RenJi Hospital
Observational
369
Shanghai
2022-06-01
Recruiting
RenJi Hospital
Observational
84
Shanghai
2022-02-01
Recruiting
Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer
NCT06391190Locally Advanced Cervical Carcinoma, Concurrent Chemoradiotherapy, Immunotherapy
RenJi Hospital
Phase 1/2
20
Shanghai
2022-01-01
Recruiting
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932Immune System and Related Disorders
RenJi Hospital
Observational
50
Shanghai
2021-02-01
Recruiting
Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture
NCT04723888Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter
RenJi Hospital
Not applicable
300
Shanghai
2021-02-01
Recruiting
RenJi Hospital
Observational
210
Shanghai
2021-01-01
Recruiting
Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
NCT07205510Sarcopenia, Metabolic Diseases, All-cause Mortality, Aging
RenJi Hospital
Observational
10,000
Shanghai
2020-12-01
Recruiting
Prospective, Observational Real-world Treatments of AEDH in Large-scale Surgical Cases
NCT04229966Epidural Hematoma, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Observational
2,000
Shanghai
2020-11-02
Active, closed
Prospective Randomized Evaluation of Decompressive Ipsilateral Craniectomy for Traumatic Acute Epidural Hematoma
NCT04261673Epidural Hematoma, Brain Herniation, Decompressive Craniectomy, Craniotomy
RenJi Hospital
Not applicable
120
Shanghai
2020-05-23
Recruiting
AAA-CTA Cohort Registry
NCT07039825Abdominal Aortic Aneurysm, Image
RenJi Hospital
Observational
1,000
Shanghai
2020-01-01
Recruiting
Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
NCT04254263Locally Advanced Breast Cancer
RenJi Hospital
Phase 3
316
Shanghai
2019-12-16
Active, closed
RenJi Hospital
Phase 2
53
Shanghai
2019-06-18
Active, closed
RenJi Hospital
Phase 2
196
Shanghai
2018-10-16
Active, closed
RenJi Hospital
Phase 2
100
Shanghai
2017-12-01
Recruiting
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
NCT03392233Breast Cancer, Prostate Cancer, Non Small Cell Lung Cancer
RenJi Hospital
Phase 2
100
Shanghai
2017-08-18
Recruiting
Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women
NCT03201861Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Duct Carcinoma of Breast
RenJi Hospital
Phase 3
762
Shanghai
2017-07-27
Recruiting
Early ECG Prediction of Multi-system Disease Cohort Establishment and Follow Up
NCT06924580Public Health, Public Health System Research, Multi-system Disease Diagnosis
RenJi Hospital
Observational
500,000
Shanghai
2017-01-18
Recruiting
RenJi Hospital
Observational
10
Shanghai
2016-01-01
Active, closed
Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients
NCT02221999Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
RenJi Hospital
Phase 2/3
250
Shenzhen, Handan, Hengyang, Hohhot, Kunshan, Yinchuan, Shanghai, Zhoushan
2013-09
Rows per page Showing 1–133 of 133
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 9 November 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 133 of those studies with a site in Shanghai that also match the filters currently applied.

How many clinical trials are recruiting in Shanghai?

86 of the 133 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 32 have not yet opened recruitment, 13 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shanghai), 133 studies
PhaseStudiesRecruitingShare
Not applicable452733.8%
Observational453733.8%
Phase 223817.3%
Early Phase 1533.8%
Phase 3433%
Phase 1322.3%
Phase 2/3322.3%
Phase 4322.3%
Phase 1/2221.5%

Most active sponsors

Lead sponsors with the most studies (Shanghai)
Lead sponsorStudiesRecruiting
RenJi Hospital13386
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.